Johnson & Johnson JNJ

$258.66 -6.08 (-2.30%)

Valuation

Market cap
644,816,384,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
PE ratio
25.04
Forward PE
23.43
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
8,292,400
Avg volume
6,680,700
Day's range
$258.33 – $263.98
Shares out
2,409,898,000
Stochastic %K
2%
Beta
0.24
Analysts
Strong Sell
Price target
$282.28

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

Outcomes Oct 1, 11:24 PM
$IBRX $JNJ $MRK $MRNA $PFE https://x.com/childrenshd/status/2105355353030332590?s=46
1 replies
Outcomes Oct 1, 10:52 PM
$IBRX $PFE $MRNA $MRK $JNJ https://x.com/deepleakshq/status/2105687388110655945?s=46
1 replies
Outcomes Oct 1, 10:50 PM
$IBRX $JNJ $MRNA $PFE https://x.com/DrLindaHarper/status/2105764694430547983/video/1?s=46
1 replies
Outcomes Oct 1, 7:56 PM
$PFE $MRNA $JNJ ......mRNA BAD. SAVE THE CHILDREN. 🙏 Now therapies like ANKTIVA from $IBRX have to clean up the mess you made. REPARATIONS. Time to pay up! https://x.com/liz_churchill10/status/2105710397252595907?s=20
1 replies
tonyp262 Oct 1, 5:38 PM
$JNJ market has turned green and this just keeps dipping
2 replies
Manny007 Oct 1, 5:21 PM
$JNJ if yo were to buy a great company ever that’s steady Eddy is this one ! I love dips I buy more sell calls and cashing ! Free money
0 replies
Symboltrader1 Oct 1, 5:07 PM
$JNJ Breaking the 50 day average after making a lower swing high = no bueno.
0 replies
tonyp262 Oct 1, 4:15 PM
$JNJ struggling to understand how this is down 1.7% again today. That’s back to back days.
1 replies